Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro

.

Source: Archives of Physiology and Biochemistry - November 3, 2023 Category: Physiology Authors: Jufen LiuHuijing WangCuiting Huanga Ophthalmology Department of Shangyu People ’s Hospital of Shaoxing City, Shaoxing, Chinab Health Management Center of Shangyu People’s Hospital of Shaoxing City, Shaoxing, Chinac Ophthalmology Department Of Ningde C Source Type: research